Clinical efficacy of Valdoxan in everyday practice conditions (efficiency).
Phase of Trial: Phase IV
Latest Information Update: 26 Dec 2017
At a glance
- Drugs Agomelatine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms Etude-VALDOXAN-D-CHANGE
- Sponsors IRIS
- 30 Apr 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 24 Jul 2009 New trial record